O. Jarrett

Publication List Details

Period

1985 - 2007

Number

74

Co-Authors

Dynamin-dependent endocytosis is necessary for convergent-extension movements in Xenopus animal cap explants (2002)

Jarrett, O., Stow, J. L., Yap, A. S., Key, B.

Cadherin cell-cell adhesion molecules are important determinants of morphogenesis and tissue patterning. C-cadherin plays a key role in the cell-upon-cell movements seen during Xenopus gastrulation....

Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence (2002)

Hosie, M.J., Willett, B.J., Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., ...

The development of an effective vaccine against human immunodeficiency virus is considered to be the most practicable means of controlling the advancing global AIDS epidemic. Studies with the...

Dynamin-dependent endocytosis is necessary for convergent-extension movements in Xenopus animal cap explants (2002)

Jarrett, O., Stow, J. L., Yap, A. S., Key, B.

Cadherin cell-cell adhesion molecules are important determinants of morphogenesis and tissue patterning. C-cadherin plays a key role in the cell-upon-cell movements seen during Xenopus gastrulation....

Dynamin-dependent endocytosis is necessary for convergent-extension movements in Xenopus animal cap explants (2002)

Jarrett, O., Stow, J. L., Yap, A. S., Key, B.

Cadherin cell-cell adhesion molecules are important determinants of morphogenesis and tissue patterning. C-cadherin plays a key role in the cell-upon-cell movements seen during Xenopus gastrulation....

Dynamin-dependent endocytosis is necessary for convergent-extension movements in Xenopus animal cap explants (2002)

Jarrett, O., Stow, J. L., Yap, A. S., Key, B.

Cadherin cell-cell adhesion molecules are important determinants of morphogenesis and tissue patterning. C-cadherin plays a key role in the cell-upon-cell movements seen during Xenopus gastrulation....

Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats (2001)

Addie, D.D., Jarrett, O.

The pattern of shedding of feline coronavirus (FCoV) was established in 155 naturally infected pet cats from 29 households over periods of up to five years. Viral RNA was detected in faeces by...

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus (2000)

Hosie, M. J., Dunsford, T., Klein, D., Willett, B.J., Cannon, C., Osbourne, R., ...

It has been shown that cats can be protected against infection with the prototypic Petaluma strain of feline immunodeficiency virus (FIVPET) using vaccines based on either inactivated virus particles...

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies (1998)

Hosie, M.J., Flynn, J.N., Rigby, M.A., Cannon, C., Dunsford, T., Mackay, N.A., ...

To test the potential of a multigene DNA vaccine against lentivirus infection, we generated a defective mutant provirus of feline immunodeficiency virus (FIV) with an in-frame deletion in pol...

A comparison of DNA amplification, isolation and serology for the detection of Chlamydia psittaci infection in cats (1998)

McDonald, M., Willett, B.J., Jarrett, O., Addie, D.D.

Chlamydia psittaci is a significant cause of conjunctivitis in cats, but can be difficult to diagnose owing to the small number of organisms in conjunctival swabs. In the United Kingdom laboratory...

Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation (1997)

Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., ...

Direct inoculation of genetic material in DNA form is a novel approach to vaccination that has proved efficacious for a number of viral agents. We are interested in the potential of this approach for...

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction (1996)

Beatty, J.A., Willett, B.J., Gault, E.A., Jarrett, O.

The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from...

Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections (1996)

Callanan, J.J., Jones, B.A., Irvine, J., Willett, B.J., McCandlish, I.A.P., Jarrett, O.

Lymphosarcoma (malignant lymphoma) is the commonest hematopoietic tumor in the cat. Many cases are associated with feline leukemia virus (FeLV) infection, but epidemiologic and experimental data...

Suppression of virus burden by immunization with feline immunodeficiency virus Env protein (1996)

Hosie, M.J., Dunsford, T.H., De Ronde, A., Willett, B.J., Cannon, C.A., Neil, J.C., ...

Whole inactivated virus (WIV) vaccines derived from the FLA cell line protect cats against challenge with feline immunodeficiency virus (FIV). To discover whether the protective effects of WIV could...

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines (1995)

Hosie, M.J., Osborne, R., Yamamoto, J.K., Neil, J.C., Jarrett, O.

Whole inactivated virus vaccines from the FL4 cell line protected against challenge with homologous feline immunodeficiency virus (Petaluma strain) but not against a heterologous FIV isolate (GL-8)...

A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor (1993)

Hosie, M.J., Willett, B.J., Dunsford, T.H., Jarrett, O., Neil, J.C.

Monoclonal antibody vpg15 detects a 24-kDa cell surface protein on feline cells permissive for infection with feline immunodeficiency virus (FIV). The antibody blocks infection of FIV-susceptible...

Induction of feline leukemia virus neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene. (1993)

Weijer, K., Pfauth, A., Herwijnen, R. Van, Jarrett, O., Meloen, R.H., Tomee, C., ...

The surface glycoprotein, gp70, of feline leukaemia virus (FeLV) contains sites which are important in inducing neutralizing antibodies. Using synthetic peptides corresponding to nucleotide sequence...

Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in the united-kingdom (1989)

Hosie, M.J., Robertson, C., Jarrett, O.

A representative sample of the pet cat population of the United Kingdom was surveyed. Blood samples from 1204 sick and 1007 healthy cats of known breed, age and sex were tested for antibodies to...

Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine. (1989)

Weijer, K., UytdeHaag, F., Knell, P., Jarrett, O., Morein, B.

Various approaches have been considered for generation of effective and safe vaccines against retroviruses, including HIV, with limited success. In the present vaccination study, encompassing 137...

Post-exposure treatment with monoclonal antibodies in a retrovirus system: failure to protect cats against feline leukemia virus infection with virus neutralizing monoclonal antibodies. (1986)

Weijer, K., Jarrett, O., Lutz, H.

We have attempted to protect kittens against oronasal infection with FeLV (strain A/Glasgow-1) by treatment with a mixture of two virus-neutralizing (VN) MAbs (IgGl, K) directed against the same...

Induction of protective immune response in cats by vaccination with feline leukemia virus iscoms. (1985)

Weijer, K., UytdeHaag, F., Jarrett, O., Sundquist, B., Morein, B.

An effective candidate subunit vaccine consisting of the gp 70/85 of feline leukemia virus (FeLV) was prepared by using the immunostimulating complex (iscom) method for the presentation of membrane...

Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence

Hosie, M.J., Willett, B.J., Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., ...

The development of an effective vaccine against human immunodeficiency virus is considered to be the most practicable means of controlling the advancing global AIDS epidemic. Studies with the...

The Receptor Binding Site of Feline Leukemia Virus Surface Glycoprotein Is Distinct from the Site Involved in Virus Neutralization

Ramsey, I. K., Spibey, N., Jarrett, O.

The external surface glycoprotein (SU) of feline leukemia virus (FeLV) contains sites which define the viral subgroup and induce virus-neutralizing antibodies. The subgroup phenotypic determinants...

Dynamics of Viral and Proviral Loads of Feline Immunodeficiency Virus within the Feline Central Nervous System during the Acute Phase following Intravenous Infection

Ryan, G., Klein, D., Knapp, E., Hosie, M. J., Grimes, T., ...

Animal models of human immunodeficiency virus 1, such as feline immunodeficiency virus (FIV), provide the opportunities to dissect the mechanisms of early interactions of the virus with the central...

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.

Hosie, M J, Osborne, R, Yamamoto, J K, Neil, J C, Jarrett, O

Whole inactivated virus vaccines from the FL4 cell line protected against challenge with homologous feline immunodeficiency virus (Petaluma strain) but not against a heterologous FIV isolate (GL-8)...

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.

Beatty, J A, Willett, B J, Gault, E A, Jarrett, O

The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from...

Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.

Flynn, J N, Cannon, C A, Neil, J C, Jarrett, O

Cats were immunized with a 46-residue multiepitopic synthetic peptide of feline immunodeficiency virus (FIV) comprising immunodominant epitopes present in the third variable domain of the envelope...

A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor.

Hosie, M J, Willett, B J, Dunsford, T H, Jarrett, O, Neil, J C

Monoclonal antibody vpg15 detects a 24-kDa cell surface protein on feline cells permissive for infection with feline immunodeficiency virus (FIV). The antibody blocks infection of FIV-susceptible...

Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.

Tartaglia, J, Jarrett, O, Neil, J C, Desmettre, P, Paoletti, E

Two ALVAC (canarypox virus)-based recombinant viruses expressing the feline leukemia virus (FeLV) subgroup A env and gag genes were assessed for their protective efficacy in cats. Both recombinant...

Detection of feline leukemia virus infection in saliva.

Lutz, H, Jarrett, O

The question was investigated whether feline leukemia virus (FeLV) infection may be diagnosed by testing saliva in an enzyme-linked immunosorbent assay (ELISA). Saliva was collected with commercially...

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

Hosie, M. J., Dunsford, T., Klein, D., Willett, B.J., Cannon, C., Osbourne, R., ...

It has been shown that cats can be protected against infection with the prototypic Petaluma strain of feline immunodeficiency virus (FIVPET) using vaccines based on either inactivated virus particles...

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies

Hosie, M.J., Flynn, J.N., Rigby, M.A., Cannon, C., Dunsford, T., Mackay, N.A., ...

To test the potential of a multigene DNA vaccine against lentivirus infection, we generated a defective mutant provirus of feline immunodeficiency virus (FIV) with an in-frame deletion in pol...

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction

Beatty, J.A., Willett, B.J., Gault, E.A., Jarrett, O.

The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from...

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

Hosie, M.J., Osborne, R., Yamamoto, J.K., Neil, J.C., Jarrett, O.

Whole inactivated virus vaccines from the FL4 cell line protected against challenge with homologous feline immunodeficiency virus (Petaluma strain) but not against a heterologous FIV isolate (GL-8)...

A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor

Hosie, M.J., Willett, B.J., Dunsford, T.H., Jarrett, O., Neil, J.C.

Monoclonal antibody vpg15 detects a 24-kDa cell surface protein on feline cells permissive for infection with feline immunodeficiency virus (FIV). The antibody blocks infection of FIV-susceptible...

The Receptor Binding Site of Feline Leukemia Virus Surface Glycoprotein Is Distinct from the Site Involved in Virus Neutralization

Ramsey, I. K., Spibey, N., Jarrett, O.

The external surface glycoprotein (SU) of feline leukemia virus (FeLV) contains sites which define the viral subgroup and induce virus-neutralizing antibodies. The subgroup phenotypic determinants...

Dynamics of Viral and Proviral Loads of Feline Immunodeficiency Virus within the Feline Central Nervous System during the Acute Phase following Intravenous Infection

Ryan, G., Klein, D., Knapp, E., Hosie, M. J., Grimes, T., ...

Animal models of human immunodeficiency virus 1, such as feline immunodeficiency virus (FIV), provide the opportunities to dissect the mechanisms of early interactions of the virus with the central...

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.

Hosie, M J, Osborne, R, Yamamoto, J K, Neil, J C, Jarrett, O

Whole inactivated virus vaccines from the FL4 cell line protected against challenge with homologous feline immunodeficiency virus (Petaluma strain) but not against a heterologous FIV isolate (GL-8)...

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.

Beatty, J A, Willett, B J, Gault, E A, Jarrett, O

The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from...

Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.

Flynn, J N, Cannon, C A, Neil, J C, Jarrett, O

Cats were immunized with a 46-residue multiepitopic synthetic peptide of feline immunodeficiency virus (FIV) comprising immunodominant epitopes present in the third variable domain of the envelope...

A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor.

Hosie, M J, Willett, B J, Dunsford, T H, Jarrett, O, Neil, J C

Monoclonal antibody vpg15 detects a 24-kDa cell surface protein on feline cells permissive for infection with feline immunodeficiency virus (FIV). The antibody blocks infection of FIV-susceptible...

Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.

Tartaglia, J, Jarrett, O, Neil, J C, Desmettre, P, Paoletti, E

Two ALVAC (canarypox virus)-based recombinant viruses expressing the feline leukemia virus (FeLV) subgroup A env and gag genes were assessed for their protective efficacy in cats. Both recombinant...

Detection of feline leukemia virus infection in saliva.

Lutz, H, Jarrett, O

The question was investigated whether feline leukemia virus (FeLV) infection may be diagnosed by testing saliva in an enzyme-linked immunosorbent assay (ELISA). Saliva was collected with commercially...

Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study.

Lawrence, C E, Callanan, J J, Willett, B J, Jarrett, O

The immune responsiveness of cats naturally or experimentally infected with feline immunodeficiency virus (FIV) was studied. Peripheral blood mononuclear cells (PBMC) from naturally infected,...

Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.

Flynn, J N, Cannon, C A, Reid, G, Rigby, M A, Neil, J C, Jarrett, O

Cytotoxic T-cell determinants should be an important component of a vaccine against feline immunodeficiency virus (FIV). Epitope mapping studies have revealed an immunodominant neutralization epitope...

Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.

Mowat, A M, Donachie, A M, Reid, G, Jarrett, O

Induction of all forms of protective immunity by oral immunization with subunit vaccines is an ideal goal for the development of novel vaccines, but creates several theoretical problems from the...

Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset.

Willett, B J, Hosie, M J, Callanan, J J, Neil, J C, Jarrett, O

Lymphocyte subset analysis was performed on specific pathogen-free cats infected with feline immunodeficiency virus (FIV). As early as 4 weeks post-infection a sharp rise in lymphocytes expressing...

Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9.

Willett, B J, Hosie, M J, Jarrett, O, Neil, J C

A monoclonal antibody vpg15 has been identified which recognizes a putative cellular receptor for feline immunodeficiency virus (FIV). The antibody immunoprecipitates a single 24,000 MW species from...

Polyclonal B-cell activation in cats infected with feline immunodeficiency virus.

Flynn, J N, Cannon, C A, Lawrence, C E, Jarrett, O

The specificity of the antibody response following natural or experimental infection of domestic cats with feline immunodeficiency virus (FIV) was examined. The antibody response to a range of...

Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence

Hosie, M.J., Willett, B.J., Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., ...

The development of an effective vaccine against human immunodeficiency virus is considered to be the most practicable means of controlling the advancing global AIDS epidemic. Studies with the...

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

Hosie, M. J., Dunsford, T., Klein, D., Willett, B.J., Cannon, C., Osbourne, R., ...

It has been shown that cats can be protected against infection with the prototypic Petaluma strain of feline immunodeficiency virus (FIVPET) using vaccines based on either inactivated virus particles...

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies

Hosie, M.J., Flynn, J.N., Rigby, M.A., Cannon, C., Dunsford, T., Mackay, N.A., ...

To test the potential of a multigene DNA vaccine against lentivirus infection, we generated a defective mutant provirus of feline immunodeficiency virus (FIV) with an in-frame deletion in pol...

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction

Beatty, J.A., Willett, B.J., Gault, E.A., Jarrett, O.

The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from...

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

Hosie, M.J., Osborne, R., Yamamoto, J.K., Neil, J.C., Jarrett, O.

Whole inactivated virus vaccines from the FL4 cell line protected against challenge with homologous feline immunodeficiency virus (Petaluma strain) but not against a heterologous FIV isolate (GL-8)...

A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor

Hosie, M.J., Willett, B.J., Dunsford, T.H., Jarrett, O., Neil, J.C.

Monoclonal antibody vpg15 detects a 24-kDa cell surface protein on feline cells permissive for infection with feline immunodeficiency virus (FIV). The antibody blocks infection of FIV-susceptible...

Dynamin-dependent endocytosis is necessary for convergent-extension movements in Xenopus animal cap explants

Jarrett, O, Stow, JL, Yap, AS, Key, B

Cadherin cell-cell adhesion molecules are important determinants of morphogenesis and tissue patterning. C-cadherin plays a key role in the cell-upon-cell movements seen during Xenopus gastrulation....

Suppression of feline immunodeficiency virus replication in vitroby a soluble factor secreted by CD8+ T lymphocytes

Flynn, J N, Cannon, C A, Sloan, D, Neil, J C, Jarrett, O

Mitogen-activated lymphoblasts isolated from the blood and lymph nodes, but not the spleen, of domestic cats acutely infected with the Petaluma or Glasgow8 isolates of feline immunodeficiency virus...

Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes

Flynn, J N, Hanlon, L, Jarrett, O

Feline leukaemia virus (FeLV) nucleic acid vaccination of domestic cats affords protection against viraemia and the development of latency without inducing antiviral antibodies.1 To determine the...